We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

605117:SSENingbo Deye Technology Co., Ltd. Class A Analysis

Data as of 2026-06-16 - not real-time

CN¥102.42

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at CNY 102.42, which sits below the 20‑day SMA of 112.20 and the 50‑day SMA of 106.44, indicating a short‑term pullback despite a bullish overall trend. Technical indicators show a neutral‑to‑bearish stance with an RSI of 42, a bearish MACD histogram of –1.94, and price holding just above the near‑term support at 98.73 while facing resistance near 126.9. Volatility is elevated at 56.9% over the past 30 days, yet the beta is extremely low at 0.018, suggesting the share moves largely independently of broader market swings, a factor reinforced by an “Extreme Greed” market sentiment reading of 92.73.
Fundamentally, Ningbo Deye delivers robust growth, posting 73.8% revenue expansion and an operating margin of 32.8%, with a stellar ROE of 33.4% and ample cash of CNY 10.45 bn against modest debt. However, valuation appears stretched: the trailing PE of 35.44 exceeds the industry average of 31.03, and the DCF‑derived fair value of 87.64 is well below the current price. The dividend yield of 2.57% is attractive, backed by a healthy payout ratio of 73% and strong free cash flow, positioning the stock as a potentially sustainable income play despite the premium valuation.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support at 98.73
  • Bearish MACD and neutral RSI
  • Valuation premium over DCF fair value

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Rapid revenue growth of 73.8% YoY
  • Strong ROE (33.4%) and operating margins
  • Attractive dividend yield with solid cash generation

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Long‑term tailwinds in solar inverter and energy storage markets
  • Potential valuation compression toward DCF levels
  • Sustainable dividend income supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth73.80%
Profit Margin25.88%
P/E Ratio35.4
ROE33.40%
ROA13.31%
Debt/Equity22.99
P/B Ratio11.3
Op. Cash FlowCN¥5.3B
Free Cash FlowCN¥2.9B
Industry P/E31.0

Technical Analysis

TrendBullish
RSI42.0
SupportCN¥98.73
ResistanceCN¥126.90
MA 20CN¥112.20
MA 50CN¥106.44
MA 200CN¥73.30
MACDBearish
VolumeStable
Fear & Greed Index92.73

Valuation

Fair ValueCN¥87.64
GradeOvervalued
TypeBlend
Dividend Yield2.57%

Risk Assessment

Beta0.02
Volatility56.88%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.